Trials / Conditions / Left Ventricular Thrombus

Left Ventricular Thrombus

17 registered clinical trials studyying Left Ventricular Thrombus — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus NCT07246005	Queen Mary University of London	Phase 2
Recruiting	Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infa NCT06515730	Karolinska Institutet	Phase 4
Recruiting	Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction NCT06742567	National Institute of Cardiovascular Diseases, Pakistan	Phase 3
Recruiting	Left Ventricular Thrombus Registry NCT06963567	Queen Mary University of London	—
Unknown	Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segme NCT06152939	Assiut University	—
Recruiting	Anticoagulation in Post MI LV Thrombus Trial in Nepal NCT05794399	Shahid Gangalal National Heart Centre	Phase 4
Unknown	Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction NCT05892042	Jilin University	N/A
Unknown	Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical T NCT05973188	Peshawar Institute of Cardiology	Phase 4
Completed	Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarct NCT05077683	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Rivaroxaban in Left Ventricular Thrombus NCT04970576	National Institute of Cardiovascular Diseases, Pakistan	Phase 4
Completed	Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute NCT05705089	Rajaie Cardiovascular Medical and Research Center	Phase 3
Unknown	Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus NCT03415386	The First Affiliated Hospital with Nanjing Medical University	Phase 4
Unknown	Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant NCT03764241	RenJi Hospital	Phase 3
Completed	The "MyoThrombus" Study NCT04829825	University of Edinburgh	—
Unknown	Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) NCT03786757	RenJi Hospital	Phase 3
Completed	Apixaban in Patients With Left Ventricular Thrombus NCT05208398	Saud Al Babtain Cardiac Center	Phase 3
Completed	Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfun NCT04871126	Henan Provincial People's Hospital	—